Loading chart…
PRE-MARKET
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company North America, Europe, India, Russia, and internationally. The company operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segment.
Dr. Reddy's Laboratories Limited (DRREDDY) is listed on the NSE in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. The DRREDDY share price is ₹1,385.00 (+0.87% today), with a market capitalisation of ₹1.15T and a price-to-earnings (P/E) ratio of 41.1. MarketRipple tracks the DRREDDY investment thesis, the ripple-chain impact of market events on Dr. Reddy's Laboratories Limited, and the Healthcare sector outlook.
Open
₹1,375.00
High
₹1,390.30
Low
₹1,369.30
Prev. Close
₹1,373.00
52W High
₹1,414.90
52W Low
₹1,101.00
Day range
₹1,369.30–₹1,390.30
52-week range
₹1,101.00–₹1,414.90
Volume
1.8M
P/E
41.1
ROE
7.3%
D/E
0.21
Margin
8.5%
Dr. Reddy's Laboratories Limited (NSE: DRREDDY) is currently trading at ₹1,385.00 (+0.87%).
Dr. Reddy's Laboratories Limited's market capitalization is ₹1.15T.
Dr. Reddy's Laboratories Limited's price-to-earnings (P/E) ratio is 41.1.
Dr. Reddy's Laboratories Limited operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic).
Analyst consensus on Dr. Reddy's Laboratories Limited currently reads positive, based on 37 analysts covering the stock. This is third-party analyst data, not a MarketRipple recommendation.